MedPath
HSA Approval

GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 200 mg/vial

SIN14925P

GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 200 mg/vial

GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 200 mg/vial

January 25, 2016

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Therapeutic

Prescription Only

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS

Medical Information

L01BC05

gemcitabine

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

Fresenius Kabi Oncology Limited

Active Ingredients

GEMCITABINE HYDROCHLORIDE EQV GEMCITABINE

200 mg/vial

Gemcitabine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GEMITA LYOPHILISED POWDER FOR SOLUTION FOR INJECTION 200 mg/vial - HSA Approval | MedPath